3 products were found matching "1020172-07-9"!
No results were found for the filter!
Rebastinib
Item number: Cay21465-1
Rebastinib is an orally bioavailable tyrosine kinase inhibitor that inhibits Abl1 (IC50 = 0.8 nM) as well as the gatekeeper mutant Abl1T315I (IC50 = 4 nM) and the activation loop mutant Abl1H396P. It also inhibits the Src family kinases Src, Lyn, Fgr, and Hck and the tyrosine kinases KDR, FLT3, and Tie2 at nanomolar...
| Keywords: | DCC-2036,... |
| Application: | ABL1 inhibitor |
| CAS | 1020172-07-9 |
| MW: | 553.6 D |
From 71.00€
*
DCC-2036
Item number: LKT-D0808.1
Abl inhibitor.
| Keywords: | DCC2036, Rebastinib |
| Application: | Tek tyrosine kinase (TIE2) inhibitor, Bcr-Abl tyrosine kinase inhibitor |
| CAS | 1020172-07-9 |
| MW: | 553.59 D |
From 143.00€
*
Rebastinib
Item number: TGM-T2640-100mg
Description: DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway. Target: FLT, Apoptosis, Bcr-Abl,...
| Keywords: | DCC2036, DCC 2036, DCC-2036 |
| CAS | 1020172-07-9 |
| MW: | 553.59 D |
From 39.00€
*
